Myriad Genetics Total Non Current Liabilities 2011-2026 | MYGN

Annual Total Non Current Liabilities Myriad Genetics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	107 M	229 M	60.1 M	35.4 M	24.2 M	10.7 M	10 M	9.65 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
229 M	9.65 M	60.8 M

Total Non Current Liabilities of other stocks in the Diagnostics research industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	23.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	3.29 B	$ 116.23	0.6 %	$ 35.3 B	USA
Akumin AKU	527 M	-	-17.87 %	$ 25.9 M	Canada
Accelerate Diagnostics AXDX	134 M	-	-61.36 %	$ 2.46 M	USA
Co-Diagnostics CODX	574 K	$ 1.67	-	$ 2.22 M	USA
Aspira Women's Health AWH	3.49 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	11.3 M	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	2.76 M	$ 25.26	3.27 %	$ 702 M	USA
Chembio Diagnostics CEMI	24.8 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	16 K	-	-	$ 9.42 M	Israel
CareDx, Inc CDNA	17.9 M	$ 21.52	1.37 %	$ 1.15 B	USA
Oxford Immunotec Global PLC OXFD	7.74 M	-	-	$ 562 M	Britain
DermTech DMTK	865 K	-	-11.32 %	$ 2.94 M	USA
Enzo Biochem ENZ	4.6 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	981 M	-	-	$ 19.8 B	USA
Illumina ILMN	2.04 B	$ 127.89	0.01 %	$ 20.3 B	USA
Fulgent Genetics FLGT	2.26 M	$ 16.19	-0.74 %	$ 490 M	USA
Global Cord Blood Corporation CO	2.53 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	131 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	559 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	48.5 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	2.35 B	$ 172.96	1.88 %	$ 8.57 B	USA
PRA Health Sciences, Inc. PRAH	1.43 B	-	-	$ 10.7 B	USA
Guardant Health GH	91.4 M	$ 90.69	2.0 %	$ 11.4 B	USA
Lantheus Holdings LNTH	225 M	$ 84.36	0.04 %	$ 5.69 B	USA
Medpace Holdings MEDP	73.8 M	$ 416.53	1.46 %	$ 12 B	USA
HTG Molecular Diagnostics HTGM	4.1 M	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	57.9 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	10 M	$ 2.0	1.27 %	$ 8.85 M	USA
Koninklijke Philips N.V. PHG	8.08 B	$ 27.72	0.91 %	$ 20 B	Niderland
Motus GI Holdings MOTS	2.16 M	-	-34.28 %	$ 263 K	Israel
Senseonics Holdings SENS	163 M	$ 7.07	0.21 %	$ 295 M	USA
QIAGEN N.V. QGEN	1.99 B	-	-	$ 10.6 B	Niderland
Neogen Corporation NEOG	19.6 M	$ 9.6	0.58 %	$ 2.08 B	USA
Soleno Therapeutics SLNO	10.8 M	$ 52.74	0.04 %	$ 2.68 B	USA
Biomerica BMRA	1.57 M	$ 2.17	1.4 %	$ 4.98 M	USA
National Research Corporation NRC	39.6 M	$ 17.26	0.17 %	$ 386 M	USA
ICON Public Limited Company ICLR	461 M	$ 102.05	-0.12 %	$ 8.42 B	Irlanda
Laboratory Corporation of America Holdings LH	7.82 B	$ 265.38	0.62 %	$ 22.1 B	USA
Thermo Fisher Scientific TMO	22.5 B	$ 470.88	0.28 %	$ 178 B	USA
Celcuity CELC	69.2 K	$ 125.51	3.7 %	$ 5.87 B	USA
Trinity Biotech plc TRIB	106 M	$ 0.65	0.03 %	$ 61.9 M	Irlanda
OpGen OPGN	21.2 M	-	-16.95 %	$ 1.54 M	USA
NeoGenomics NEO	435 M	$ 8.43	1.69 %	$ 1.08 B	USA
Twist Bioscience Corporation TWST	4.56 M	$ 60.75	-0.31 %	$ 3.63 B	USA
Natera NTRA	124 M	$ 206.25	1.23 %	$ 20.3 B	USA
Quest Diagnostics Incorporated DGX	5.17 B	$ 197.24	0.52 %	$ 21.9 B	USA
Invitae Corporation NVTA	320 M	-	-	$ 21.2 M	USA
PerkinElmer PKI	2.96 B	-	-0.91 %	$ 14.7 B	USA